David McGarry, DO
Allergy & Immunology · Spokane Valley, WANPI 1093135188
Payments from drug & device makers
Across 520 payments — averaging $127.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$40K
- AstraZeneca$20K
- Genentech USA, Inc.$2K
- Amgen$881
- Biocryst US Sales Co., LLC$648
- Takeda Pharmaceuticals U.S.A., Inc.$626
- plus $3K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 111 | $40,021 |
| AstraZeneca | 129 | $19,850 |
| Genentech USA, Inc. | 18 | $1,655 |
| Amgen(2 entities) | 59 | $881 |
| Biocryst US Sales Co., LLC | 30 | $648 |
| Takeda Pharmaceuticals U.S.A., Inc. | 44 | $626 |
| Novartis | 31 | $529 |
| Pharming Healthcare, Inc. | 17 | $327 |
| CSL Behring | 16 | $296 |
| Blueprint Medicines Corporation | 10 | $234 |
| Regeneron Healthcare Solutions, Inc. | 8 | $164 |
| Grifols USA, LLC | 7 | $133 |
| ADMA Biomanufacturing LLC | 5 | $128 |
| Pfizer | 5 | $86 |
| Sanofi | 4 | $69 |
| Boehringer Ingelheim | 3 | $62 |
| BD | 1 | $50 |
| Ionis Pharmaceuticals, Inc. | 2 | $47 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $46 |
| LEO Pharma Inc. | 2 | $45 |
| Alk-abello, Inc | 2 | $44 |
| Lilly USA, LLC | 2 | $43 |
| Verona Pharma, Inc. | 2 | $36 |
| Tersera Therapeutics LLC | 1 | $32 |
| Cycle Pharmaceuticals Inc | 1 | $30 |
| Paratek Pharmaceuticals, Inc. | 1 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| Shire North American Group Inc | 2 | $25 |
| Octapharma USA, Inc. | 1 | $22 |
| X4 Pharmaceuticals, Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $17 |
How this compares
$66,241 in reported general payments places this provider in the 85th percentile of 81 allergy & immunology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Spokane Valley
- Ritu PabbySpokane Valley$8K
- David ElkayamBellingham$2.1M
- Daniel PetroniSeattle$2M
- Richard GowerSpokane$1.1M
- Sanjeev JainLongview$392K
- William HendersonSeattle$296K
- Taiil SongLakewood$192K
- Mary FarringtonSeattle$176K
- Frank VirantSeattle$107K
- Leonard AltmanSeattle$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.